Follow Healthline   |   Healthline on TwitterTwitter   |   Healthline on FacebookFacebook
Symptom Search   |   Treatment Search   |   Doctor Search   |   Drug Search

Retinal Vein Occlusion : News

Healthline Premium Tools

Advertisement
Marketplace

News: November 25, 2009

Sanofi-Aventis to acquire Fovea Pharmaceuticals
... undergoing clinical development, including a treatment for persistent allergic conjunctivitis in phase 2 trials, a retinal vein occlusion-induced macular edema treatment in phase 1 trials and a diabetic macular edema drug set to enter phase 1 trials ...
Source:Drug Store News
Date:October 2, 2009
Fovea Pharmaceuticals to be Acquired by sanofi-av...
... FOV 2302, an intravitreal formulation of a plasma kallikrein inhibitor, in phase I for the treatment of Retinal Vein Occlusion induced macular edema and FOV 2304, a potent antagonist of bradykinin B1 receptor, active by eye drop, scheduled to enter ...
Source:Drugs.com
Date:October 1, 2009
Fovea Pharmaceuticals to be Acquired by Sanofi-Av...
... FOV 2302, an intravitreal formulation of a plasma kallikrein inhibitor, in phase I for the treatment of Retinal Vein Occlusion induced macular edema and FOV 2304, a potent antagonist of bradykinin B1 receptor, active by eye drop, scheduled to enter ...
Source:BioSpace
Date:October 1, 2009
pSivida Anounces New Iluvien(R) Pilot Study In Pa...
... has begun for a pilot study to assess the safety and efficacy of Iluvien in patients with macular edema secondary to retinal vein occlusion. The trial is being sponsored by pSivida's licensee, Alimera Sciences of Alpharetta, Georgia. The randomized, ...
Source:MediLexicon
Date:September 25, 2009
New Treatment Reduces Vision Loss
... to reverse vision loss caused by blockage of large veins in the eye. The Standard Care vs. Corticosteroid for Retinal Vein Occlusion (SCORE) study found that eye injections of a corticosteroid medication could reduce vision loss caused by the ...
Source:Health Scout
Date:September 17, 2009
Eye Injections Of Corticosteroid Medication May I...
... by the National Eye Institute (NEI) at the National Institutes of Health. The Standard Care vs. Corticosteroid for Retinal Vein Occlusion (SCORE) study, conducted at 84 clinical sites, found that eye injections of a corticosteroid medication could ...
Source:Medical News Today
Date:September 17, 2009
Steroid Restores Vision When Veins in Eye Become ...
... compelling results, because a large, longer-term clinical trial has never before shown that patients with central retinal vein occlusion could experience a visual improvement with treatment," Dr. Michael S. Ip, chair of the study and an associate ...
Source:WAFF-TV Huntsville
Date:September 15, 2009
Enrollment Completed In Regeneron And Bayer Healt...
... AG for the potential treatment of eye diseases, including wet AMD, diabetic macular edema (DME), and Central Retinal Vein Occlusion (CRVO). Regeneron maintains exclusive rights to VEGF Trap-Eye in the United States. Bayer HealthCare has exclusive ...
Source:Medical News Today
Date:September 15, 2009
Steroid Restores Vision When Veins in Eye Become ...
... compelling results, because a large, longer-term clinical trial has never before shown that patients with central retinal vein occlusion could experience a visual improvement with treatment," Dr. Michael S. Ip, chair of the study and an associate ...
Source:MedicineNet
Date:September 15, 2009
Advertisement
Back to Top